2-methylthio-atp has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornish, JE; Gargett, CE; Wiley, JS | 1 |
| Gargett, CE; Jamieson, GP; Snook, MB; Wiley, JS; Zhang, W | 1 |
2 other study(ies) available for 2-methylthio-atp and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides | 1997 |
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
Topics: Adenosine Triphosphate; B-Lymphocytes; Barium; Calcium; Cell Membrane Permeability; Cells, Cultured; Cloning, Molecular; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Macrophages; Monocytes; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides | 1998 |